Comerica Bank cut its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 30.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,719 shares of the medical instruments supplier’s stock after selling 18,614 shares during the period. Comerica Bank’s holdings in DENTSPLY SIRONA were worth $1,536,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently added to or reduced their stakes in the company. Manitou Investment Management Ltd. acquired a new stake in DENTSPLY SIRONA during the 3rd quarter valued at approximately $28,582,000. Anchor Capital Advisors LLC lifted its stake in shares of DENTSPLY SIRONA by 2.2% in the 3rd quarter. Anchor Capital Advisors LLC now owns 434,802 shares of the medical instruments supplier’s stock valued at $16,409,000 after purchasing an additional 9,388 shares during the period. Financial Counselors Inc. lifted its stake in shares of DENTSPLY SIRONA by 353.9% in the 3rd quarter. Financial Counselors Inc. now owns 53,969 shares of the medical instruments supplier’s stock valued at $2,037,000 after purchasing an additional 42,078 shares during the period. Robecosam AG lifted its stake in shares of DENTSPLY SIRONA by 17.8% in the 3rd quarter. Robecosam AG now owns 355,300 shares of the medical instruments supplier’s stock valued at $13,484,000 after purchasing an additional 53,783 shares during the period. Finally, Lapides Asset Management LLC acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at $6,586,000. Institutional investors own 96.21% of the company’s stock.
Several equities analysts recently issued reports on XRAY shares. ValuEngine lowered shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a report on Tuesday, September 4th. BidaskClub lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Thursday, September 27th. Goldman Sachs Group raised shares of DENTSPLY SIRONA from a “sell” rating to a “buy” rating and set a $44.00 price target for the company in a report on Friday, October 19th. Zacks Investment Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, August 6th. Finally, Stephens lowered shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $75.00 price target for the company. in a report on Wednesday, August 8th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and six have assigned a buy rating to the company. DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $51.50.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 8.68% and a negative net margin of 41.97%. The business had revenue of $928.40 million for the quarter, compared to analysts’ expectations of $951.58 million. During the same period in the previous year, the company earned $0.70 EPS. DENTSPLY SIRONA’s quarterly revenue was down 8.0% compared to the same quarter last year. Equities research analysts expect that DENTSPLY SIRONA Inc will post 1.97 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “DENTSPLY SIRONA Inc (XRAY) Position Reduced by Comerica Bank” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.com-unik.info/2018/12/04/dentsply-sirona-inc-xray-position-reduced-by-comerica-bank.html.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Further Reading: What are the Different Types of Leveraged Buyouts?
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.